BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10875972)

  • 1. Chemotherapy for low-grade gliomas.
    Mason WP
    Forum (Genova); 2000; 10(2):95-104. PubMed ID: 10875972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of oligodendroglial tumours: current developments.
    van den Bent MJ
    Forum (Genova); 2000; 10(2):108-18. PubMed ID: 10875973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.
    Jenkinson MD; Smith TS; Joyce KA; Fildes D; Broome J; du Plessis DG; Haylock B; Husband DJ; Warnke PC; Walker C
    Neuroradiology; 2006 Oct; 48(10):703-13. PubMed ID: 16937145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
    Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
    Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
    Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives for the diagnosis and treatment of oligodendroglioma.
    van den Bent MJ
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):348-56. PubMed ID: 12113102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade oligodendroglioma: current treatments and future hopes.
    Lwin Z; Gan HK; Mason WP
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1651-61. PubMed ID: 19895248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of primary malignant brain tumors in adults].
    Hoang-Xuan K; Delattre JY
    Rev Prat; 1996 Feb; 46(4):450-6. PubMed ID: 8729351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for high-grade gliomas.
    Galanis E; Buckner J
    Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gliomas in adults: primary non-surgical treatment].
    Poulsen HS
    Ugeskr Laeger; 2006 Nov; 168(47):4082-5. PubMed ID: 17134603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of cerebral tumours: data on malignant gliomas (author's transl)].
    Schiffer D; Giordana MT; Liboni W; Ravetti C; Soffietti R; Tarenzi L; Sannazzari GL; Negri GL
    Riv Patol Nerv Ment; 1978; 99(6):327-42. PubMed ID: 756619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
    Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
    Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical management of malignant gliomas].
    Béhin A; Delattre JY
    Cancer Radiother; 2000 Nov; 4 Suppl 1():67s-83s. PubMed ID: 11194966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade gliomas, mixed gliomas, and oligodendrogliomas.
    Macdonald DR
    Semin Oncol; 1994 Apr; 21(2):236-48. PubMed ID: 8153667
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of oligodendroglioma: an update.
    Paleologos NA; Cairncross JG
    Neuro Oncol; 1999 Jan; 1(1):61-8. PubMed ID: 11550303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
    Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
    Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing management of low-grade astrocytomas and oligodendrogliomas.
    Agulnik M; Mason WP
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1249-66. PubMed ID: 17113461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.
    Walker C; du Plessis DG; Fildes D; Haylock B; Husband D; Jenkinson MD; Joyce KA; Broome J; Kopitski K; Prosser J; Smith T; Vinjamuri S; Warnke PC
    Clin Cancer Res; 2004 Nov; 10(21):7182-91. PubMed ID: 15534091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term results of treatment in patients with oligodendrogliomas and oligoastrocytomas of the cerebral hemispheres].
    Iun'pén V; Oliushin VE; Ulitin AIu; Maslova LN; Petrov AA
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (2):6-10; discussion 10-1. PubMed ID: 18720725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.